YORKLINCS LTD

Company Registration Number:
11548219 (England and Wales)

Unaudited abridged accounts for the year ended 31 October 2025

Period of accounts

Start date: 01 November 2024

End date: 31 October 2025

YORKLINCS LTD

Contents of the Financial Statements

for the Period Ended 31 October 2025

Balance sheet
Notes

YORKLINCS LTD

Balance sheet

As at 31 October 2025


Notes
2025
2024


£
£
Fixed assets
Tangible assets: 3 45,483 58,520
Total fixed assets: 45,483 58,520
Current assets
Debtors:   41,156 21,130
Cash at bank and in hand: 36,230 20,476
Total current assets: 77,386 41,606
Creditors: amounts falling due within one year:   (52,917) (41,012)
Net current assets (liabilities): 24,469 594
Total assets less current liabilities: 69,952 59,114
Total net assets (liabilities): 69,952 59,114
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 69,852 59,014
Shareholders funds: 69,952 59,114

The notes form part of these financial statements

YORKLINCS LTD

Balance sheet statements

For the year ending 31 October 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 23 July 2026
and signed on behalf of the board by:

Name: Mr A Issott
Status: Director

The notes form part of these financial statements

YORKLINCS LTD

Notes to the Financial Statements

for the Period Ended 31 October 2025

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

Turnover policy

The turnover represents amounts receivable for goods and services net of VAT and trade discounts.

Tangible fixed assets and depreciation policy

Annual depreciation of tangible fixed assets is calculated to write off the costs of the assets, less their estimated realisable value, over their estimated useful lives. Rates are applied on a reducing balance basis over lives between 2 and 10 years.

YORKLINCS LTD

Notes to the Financial Statements

for the Period Ended 31 October 2025

2. Employees

2025 2024
Average number of employees during the period 1 1

YORKLINCS LTD

Notes to the Financial Statements

for the Period Ended 31 October 2025

3. Tangible Assets

Total
Cost £
At 01 November 2024 100,723
Additions 2,037
At 31 October 2025 102,760
Depreciation
At 01 November 2024 42,203
Charge for year 15,074
At 31 October 2025 57,277
Net book value
At 31 October 2025 45,483
At 31 October 2024 58,520

YORKLINCS LTD

Notes to the Financial Statements

for the Period Ended 31 October 2025

4. Related party transactions

Name of the related party: Mr A Issott and Mrs DJ Issott
Relationship:
Shareholders
Description of the Transaction: The shareholders have provided funding loans to the company. These loans are repayable on demand and pay interest at a commercial rate.
£
Balance at 01 November 2024 29,981
Balance at 31 October 2025 30,876